Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma.

导出 LinkOut

翻译打印收藏纠错

作者： Shuto,Negishi ^[1] ; James H,Girsch ^[2] ; Elizabeth L,Siegler ^[3] ; Evandro D,Bezerra ^[4] ; Kotaro,Miyao ^[5] ; R Leo,Sakemura ^[3]

作者单位： Department of Hematology and Oncology, Konan Kosei Hospital, Konan, Japan. ^[1] T Cell Engineering, Mayo Clinic, Rochester, MN, United States.;Division of Hematology, Mayo Clinic, Rochester, MN, United States.;Mayo Clinic Graduate School of Biomedical Sciences, Rochester, MN, United States.;Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States. ^[2] T Cell Engineering, Mayo Clinic, Rochester, MN, United States.;Division of Hematology, Mayo Clinic, Rochester, MN, United States. ^[3] Department of Hematology and Oncology, Ohio State University, Columbus, OH, United States. ^[4] Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan. ^[5]

关键词 B-cell lymphoma CAR T-cell therapy real-world data relapsed/refractory salvage therapies

DOI 10.3389/fped.2023.1305657

PMID 38283399

发布时间 2024-10-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in pediatrics

2023年11卷

1305657页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma.

Frontiers in pediatrics

相似文献

Frontiers in pediatrics

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma.

Frontiers in pediatrics

相似文献

Frontiers in pediatrics

相关期刊

检索历史清除